Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Art and medicine

Dr Soumitra Shankar Datta - Tata Medical Centre, Kolkata, India
Art and medicine ( Dr Soumitra Shankar Datta - Tata Medical Centre, Kolkata, India )
13 Jan 2022

Empathy in cancer care

Dr Soumitra Shankar Datta - Tata Medical Centre, Kolkata, India
Empathy in cancer care ( Dr Soumitra Shankar Datta - Tata Medical Centre, Kolkata, India )
13 Jan 2022

Teamwork in cancer care

Dr Soumitra Shankar Datta - Tata Medical Centre, Kolkata, India
Teamwork in cancer care ( Dr Soumitra Shankar Datta - Tata Medical Centre, Kolkata, India )
13 Jan 2022

Dihydropyrimidine dehydrogenase polymorphisms knocking on the door

Dr Mauro Daniel Donadio - AC Camargo Cancer Center, Sao Paulo, Brazil
Dihydropyrimidine dehydrogenase polymorphisms knocking on the door ( Dr Mauro Daniel Donadio - AC Camargo Cancer Center, Sao Paulo, Brazil )
11 Jan 2022

Social distancing and economic crisis in Latin America during the COVID-19 pandemic

Prof Richard Sullivan and Prof Bettina Müller
Social distancing and economic crisis in Latin America during the COVID-19 pandemic ( Prof Richard Sullivan and Prof Bettina Müller )
10 Jan 2022

Frontline treatment with single agent pembrolizumab followed by AVD chemotherapy for classic Hodgkin lymphoma

Prof Pamela Allen - Emory University School of Medicine, Georgia, USA
Frontline treatment with single agent pembrolizumab followed by AVD chemotherapy for classic Hodgkin lymphoma ( Prof Pamela Allen - Emory University School of Medicine, Georgia, USA )
22 Dec 2021

SERD vs investigator’s choice of endocrine monotherapy for ER+/HER2-advanced/mBC

Dr Aditya Bardia - Mass General Cancer Center, Boston, USA
SERD vs investigator’s choice of endocrine monotherapy for ER+/HER2-advanced/mBC ( Dr Aditya Bardia - Mass General Cancer Center, Boston, USA )
22 Dec 2021

Trastuzumab deruxtecan shows benefit across HER2+ metastatic breast cancer subgroups

Dr Sara Hurvitz - University of California, Los Angeles, USA
Trastuzumab deruxtecan shows benefit across HER2+ metastatic breast cancer subgroups ( Dr Sara Hurvitz - University of California, Los Angeles, USA )
21 Dec 2021

Neratinib + fulvestrant + trastuzumab for HR+ HER2-mutant mBC and neratinib + trastuzumab for triple-negative disease

Dr Komal Jhaveri - Memorial Sloan-Kettering Cancer Center, New York, USA
Neratinib + fulvestrant + trastuzumab for HR+ HER2-mutant mBC and neratinib + trastuzumab for triple-negative disease ( Dr Komal Jhaveri - Memorial Sloan-Kettering Cancer Center, New York, USA )
21 Dec 2021

Efficacy and safety of selinexor in patients with myelofibrosis refractory or intolerant to JAK inhibitors

Prof Srinivas Tantravahi - University of Utah, Salt Lake City, USA
Efficacy and safety of selinexor in patients with myelofibrosis refractory or intolerant to JAK inhibitors ( Prof Srinivas Tantravahi - University of Utah, Salt Lake City, USA )
20 Dec 2021

Significance of gut microbiota in patients receiving CAR T cell immunotherapy

Prof Marco Ruella - University of Pennsylvania, Philadelphia, USA
Significance of gut microbiota in patients receiving CAR T cell immunotherapy ( Prof Marco Ruella - University of Pennsylvania, Philadelphia, USA )
17 Dec 2021

The RxPONDER trial and its impact on best clinical practice

Prof Christos Markopoulos and Prof Giuseppe Curigliano
The RxPONDER trial and its impact on best clinical practice ( Prof Christos Markopoulos and Prof Giuseppe Curigliano )
17 Dec 2021